<p>Cresco Labs（OTCMKTS:CRLBF - 獲取免費報告）於週五公佈了其財報。公司報告本季度每股收益為（$0.04），低於分析師一致預期的（$0.03），差距為（$0.01），據 Zacks 報道。Cresco Labs 的淨利潤率為負 20.65%，股本回報率為負 16.61%。</p>
<h2>Cresco Labs 股票表現</h2>
<ul>
<li>大麻行業的十億美元減税</li>
</ul>
<p>OTCMKTS:CRLBF 在週五的午盤交易中下跌了$0.07，達到$1.03。該股票的交易量為 1,725,173 股，而其平均交易量為 936,485 股。該公司的市值為 5.1784 億美元，市盈率為-2.64，貝塔值為 1.59。Cresco Labs 的 12 個月低點為$0.43，12 個月高點為$2.30。該公司的 50 日簡單移動平均為$0.98，200 日簡單移動平均為$1.06。公司的速動比率為 1.60，流動比率為 2.59，債務與股本比率為 1.72。</p>
<h2>華爾街分析師觀點</h2>
<p>另外，Zacks Research 在 3 月 31 日（星期二）的一份報告中將 Cresco Labs 的股票評級從 “強烈賣出” 上調至 “持有”。一位股票研究分析師給予該股票 “強烈買入” 評級，另一位則給予公司 “持有” 評級。根據 MarketBeat 的數據，該公司的平均評級為 “買入”。</p>
<p><strong>查看我們關於 Cresco Labs 的最新研究報告</strong></p>
<h2>Cresco Labs 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Cresco Labs 是一家在美國運營的垂直整合多州大麻公司。該公司從事各種大麻產品的種植、製造和分銷，包括花朵、預捲煙、濃縮物、蒸汽器、食用產品和酊劑。Cresco Labs 的運營涵蓋種植設施、加工實驗室以及一個批發分銷中心網絡，向關鍵大麻市場的持牌藥房和零售商供應產品。</p>
<p>公司的產品組合分為多個品牌平台，如 MÜV、Reserve 和 High Supply，旨在滿足成人使用和醫療大麻市場的不同細分市場。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們認為比 Cresco Labs 更好的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 Cresco Labs 嗎？</h2>
<p>在考慮 Cresco Labs 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Cresco Labs 並不在名單上。</p>
<p>雖然 Cresco Labs 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

CRLBF

<p>Cresco Labs (OTCMKTS:CRLBF) 報告季度每股收益為（$0.04），低於預期 $0.01。該公司的股本回報率為負，達到 16.61%，淨利潤率為負，達到 20.65%。股票交易價格下跌至 $1.03，市值為 5.1784 億美元。分析師的評級不一，有一項強烈買入和一項持有。Cresco Labs 運營於大麻行業，提供多種產品，覆蓋多個市場</p>

<p>Cresco Labs (OTCMKTS:CRLBF - Get Free Report) announced its earnings results on Friday. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.01), Zacks reports. Cresco Labs had a negative net margin of 20.65% and a negative return on equity of 16.61%.</p>
<div class="lb-trans"><p>Cresco Labs（OTCMKTS:CRLBF - 獲取免費報告）於週五公佈了其財報。公司報告本季度每股收益為（$0.04），低於分析師一致預期的（$0.03），差距為（$0.01），據 Zacks 報道。Cresco Labs 的淨利潤率為負 20.65%，股本回報率為負 16.61%。</p>
</div><h2>Cresco Labs Stock Performance</h2>
<div class="lb-trans"><h2>Cresco Labs 股票表現</h2>
</div><ul>
<li>The Cannabis Sector's Billion-Dollar Tax Cut</li>
</ul>
<div class="lb-trans"><ul>
<li>大麻行業的十億美元減税</li>
</ul>
</div><p>OTCMKTS:CRLBF traded down $0.07 during midday trading on Friday, reaching $1.03. The stock had a trading volume of 1,725,173 shares, compared to its average volume of 936,485. The stock has a market cap of $517.84 million, a P/E ratio of -2.64 and a beta of 1.59. Cresco Labs has a 12-month low of $0.43 and a 12-month high of $2.30. The firm has a fifty day simple moving average of $0.98 and a two-hundred day simple moving average of $1.06. The company has a quick ratio of 1.60, a current ratio of 2.59 and a debt-to-equity ratio of 1.72.</p>
<div class="lb-trans"><p>OTCMKTS:CRLBF 在週五的午盤交易中下跌了$0.07，達到$1.03。該股票的交易量為 1,725,173 股，而其平均交易量為 936,485 股。該公司的市值為 5.1784 億美元，市盈率為-2.64，貝塔值為 1.59。Cresco Labs 的 12 個月低點為$0.43，12 個月高點為$2.30。該公司的 50 日簡單移動平均為$0.98，200 日簡單移動平均為$1.06。公司的速動比率為 1.60，流動比率為 2.59，債務與股本比率為 1.72。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Separately, Zacks Research raised shares of Cresco Labs from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report on Tuesday, March 31st. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company has an average rating of &#34;Buy&#34;.</p>
<div class="lb-trans"><p>另外，Zacks Research 在 3 月 31 日（星期二）的一份報告中將 Cresco Labs 的股票評級從 “強烈賣出” 上調至 “持有”。一位股票研究分析師給予該股票 “強烈買入” 評級，另一位則給予公司 “持有” 評級。根據 MarketBeat 的數據，該公司的平均評級為 “買入”。</p>
</div><p><strong>Check Out Our Latest Research Report on Cresco Labs</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Cresco Labs 的最新研究報告</strong></p>
</div><h2>Cresco Labs Company Profile</h2>
<div class="lb-trans"><h2>Cresco Labs 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Cresco Labs is a vertically integrated, multi-state cannabis operator in the United States. The company engages in the cultivation, manufacturing and distribution of a broad range of cannabis products, including flower, pre-rolled joints, concentrates, vaporizers, edibles and tinctures. Cresco Labs' operations span cultivation facilities, processing laboratories and a network of wholesale distribution centers that supply licensed dispensaries and retail outlets across key cannabis markets.</p>
<div class="lb-trans"><p>Cresco Labs 是一家在美國運營的垂直整合多州大麻公司。該公司從事各種大麻產品的種植、製造和分銷，包括花朵、預捲煙、濃縮物、蒸汽器、食用產品和酊劑。Cresco Labs 的運營涵蓋種植設施、加工實驗室以及一個批發分銷中心網絡，向關鍵大麻市場的持牌藥房和零售商供應產品。</p>
</div><p>The company's product portfolio is organized under several branded platforms, such as MÜV, Reserve and High Supply, each designed to address different segments of the adult-use and medical cannabis markets.</p>
<div class="lb-trans"><p>公司的產品組合分為多個品牌平台，如 MÜV、Reserve 和 High Supply，旨在滿足成人使用和醫療大麻市場的不同細分市場。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Cresco Labs</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Cresco Labs 更好的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=OTCMKTS&amp;Symbol=CRLBF"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cresco Labs Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 Cresco Labs 嗎？</h2>
</div><p>Before you consider Cresco Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cresco Labs 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Cresco Labs 並不在名單上。</p>
</div><p>While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cresco Labs 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Cresco Labs (OTCMKTS:CRLBF) 公佈財報，每股收益比預期低 0.01 美元